Analysts raise Keurig Dr Pepper targets as they assess its planned split
Keurig Dr Pepper’s fair value estimate rose to US$38.82 from US$36.97 as analysts reassessed its outlook amid plans to split into Global Coffee Co and Beverage Co. Several firms raised targets to US$39–US$41, while Wolfe Research initiated coverage with an Outperform rating and US$42 target. Analysts cited brand strength and beverage performance, while noting concerns about U.S. coffee demand and the split.
Keurig Dr Pepper’s U.S. refreshment beverage sales rise 10.9%
Keurig Dr Pepper’s U.S. Refreshment Beverages sales rose 10.9% year over year in the third quarter of 2026, driven by volume/mix growth and pricing; operating income increased 8.3%. Dr Pepper, Canada Dry, GHOST and Electrolit posted strong growth, with GHOST helping KDP’s energy portfolio exceed 10% market share. Management expects momentum to continue in the fourth quarter.
Keurig Dr Pepper lowers 2026 original-business EPS growth guidance
Keurig Dr Pepper lowered 2026 EPS growth guidance for its original business to 3%–5% from 4%–6% as consumers shift from K-Cup pods toward cheaper coffee formats and private label. Pod shipments rose just 0.3% in Q3, and coffee profit recovery was slower than expected despite higher reported segment income that included tariff refunds.
Keurig Dr Pepper prices and completes $2 billion share offering
Keurig Dr Pepper priced a public offering of 57,971,015 common shares at $34.50 each, with a 30-day option for underwriters to buy up to 8,695,652 additional shares. The company expected to use about $2 billion in proceeds to repay or repurchase debt ahead of its planned early-2027 separation into Beverage Co. and Global Coffee Co.
Dr Pepper gains fountain distribution at Jersey Mike’s
Keurig Dr Pepper added Dr Pepper fountain distribution at Jersey Mike’s in the third quarter of fiscal 2026, building on its broad foodservice presence and potential placements at other chains. Dr Pepper posted double-digit net sales growth and continued market-share gains, while Dr Pepper Zero’s retail sales rose 25% and exceeded $1 billion in annualized sales.
Analysts raise Keurig Dr Pepper price targets to $38–$41
Analysts raised Keurig Dr Pepper price targets to US$38–US$41, citing beverage strength, improving coffee trends and the planned separation into Global Coffee Co and Beverage Co by early 2027. Concerns remain over U.S. coffee demand, profit trends and investor confidence in the future coffee business. The company’s estimated fair value edged up from US$36.21 to US$36.97.
Keurig Dr Pepper reaffirms outlook as US coffee demand weakens
Keurig Dr Pepper reported Q3 sales growth of 70.1%, boosted by JDE Peet’s, while legacy sales rose 8.6% and adjusted EPS increased 22.2%. Refreshment beverages remained strong, but U.S. Coffee faced softer single-serve demand and shifts toward cheaper formats. KDP lowered legacy EPS growth guidance to 3%–5% while reaffirming its full-year sales and EPS outlook.
Most analysts rate Keurig Dr Pepper shares Buy or Hold
Keurig Dr Pepper shares have outperformed the broader market and beverage ETF over the past year and year to date. Analysts expect 2026 diluted EPS to rise 12.2% to $2.30. Of 17 analysts, 11 rate the stock Buy or Moderate Buy and six rate it Hold. Shares at $36.82 exceed the $36.22 average target, while RBC’s $42 target implies 14.1% upside.
Keurig Dr Pepper launches the Alta brewer with compostable coffee pods
Keurig Dr Pepper launched the Keurig Alta at-home brewer for espresso and café-style drinks, alongside plastic-free, compostable AltaRounds pods. The $499.99 system remains compatible with K-Cup pods. The launch aims to address U.S. Coffee profitability challenges with a higher-value product and sustainable format, though its impact depends on consumer adoption and partner-brand uptake.